Related references
Note: Only part of the references are listed.Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database
C. Gastaldon et al.
PSYCHOLOGICAL MEDICINE (2023)
The use of erenumab for migraine prophylaxis during pregnancy: A case report and narrative review
Sierra J. Vig et al.
HEADACHE (2022)
Exposure to Tramadol During Early Pregnancy and Risk of Spontaneous Abortion or Major Congenital Malformations
Anne Mette Skov Sorensen et al.
OBSTETRICS AND GYNECOLOGY (2022)
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention-2022 update
Simona Sacco et al.
JOURNAL OF HEADACHE AND PAIN (2022)
Gestational exposure to erenumab-The outcome of three pregnancies
Goncalo Bonifacio et al.
HEADACHE (2022)
Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database
Roberta Noseda et al.
CEPHALALGIA (2021)
Erenumab during pregnancy: a case report in a patient with chronic migraine
Luisa Fofi et al.
NEUROLOGICAL SCIENCES (2021)
Signal Detection in EUROmediCAT: Identification and Evaluation of Medication-Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference
Alana Cavadino et al.
DRUG SAFETY (2021)
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
Jessica Ailani et al.
HEADACHE (2021)
Pregravid Oral Contraceptive Use and the Risk of Preterm Birth, Low Birth Weight, and Spontaneous Abortion: A Systematic Review and Meta-Analysis
Rong Tang et al.
JOURNAL OF WOMENS HEALTH (2020)
Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data
Marieke M. Beex-Oosterhuis et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)
Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019
Jonathan Bearak et al.
LANCET GLOBAL HEALTH (2020)
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
Emanuel Raschi et al.
TARGETED ONCOLOGY (2020)
Migraine during pregnancy and in the puerperium
Gianni Allais et al.
NEUROLOGICAL SCIENCES (2019)
Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion
Odile Sheehy et al.
JAMA PSYCHIATRY (2019)
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Maurizio Sessa et al.
SCIENTIFIC REPORTS (2019)
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the US Food and Drug Administration Adverse Event Reporting System
Emanuel Raschi et al.
ONCOLOGIST (2019)
Associations Between Migraine and Adverse Pregnancy Outcomes: Systematic Review and Meta-analysis
Annet M. Aukes et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2019)
Use of nonsteroidal antiinflammatory drugs during pregnancy and the risk of miscarriage
De-Kun Li et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review
Per Damkier et al.
CNS DRUGS (2018)
Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation
Asher Ornoy
PHARMACEUTICAL RESEARCH (2018)
Effect of maternal age on the risk of preterm birth: A large cohort study
Florent Fuchs et al.
PLOS ONE (2018)
Pregnancy outcomes after maternal betahistine exposure: A case series
Cuneyt Kemal Buharalioglu et al.
REPRODUCTIVE TOXICOLOGY (2018)
CGRP Antibodies as Prophylaxis in Migraine
Lars Edvinsson
CELL (2018)
Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study
Kevin Spielmann et al.
CEPHALALGIA (2018)
Safety of Pregabalin in Pregnancy
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases
Suzie Seabroke et al.
DRUG SAFETY (2016)
Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase®
Francois Montastruc et al.
DRUG SAFETY (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Pharmacological treatment of migraine during pregnancy and breastfeeding
Siri Amundsen et al.
NATURE REVIEWS NEUROLOGY (2015)
Antiepileptic drugs and intrauterine death A prospective observational study from EURAP
Torbjoern Tomson et al.
NEUROLOGY (2015)
Calcitonin gene- and parathyroid hormone-related peptides in normotensive and preeclamptic pregnancies: a nested case-control study
Sonali Yadav et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
First-trimester antihistamine exposure and risk of spontaneous abortion or preterm birth
Tiara D. Aldridge et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes
Bjorn Pasternak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prenatal Antidepressant Exposure and Risk of Spontaneous Abortion - A Population-Based Study
Maiken Ina Siegismund Kjaersgaard et al.
PLOS ONE (2013)
Hypothyroidism in pregnancy
Weiping Teng et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Effects of codeine on pregnancy outcome: results from a large population-based cohort study
Katerina Nezvalova-Henriksen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Use of antidepressants during pregnancy and the risk of spontaneous abortion
Hamid Reza Nakhai-Pour et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Safety Concerns Associated With the Use of Serotonin Reuptake Inhibitors and Other Serotonergic/Noradrenergic Antidepressants During Pregnancy: A Review
Marco Tuccori et al.
CLINICAL THERAPEUTICS (2009)
VigiBase, the WHO Global ICSR Database System: Basic facts
Marie Lindquist
DRUG INFORMATION JOURNAL (2008)
Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: A population-based observational study
C Ratanajamit et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Infusion of pregnant rats with calcitonin gene-related peptide (CGRP)8-37, a CGRP receptor antagonist, increases blood pressure and fetal mortality and decreases fetal growth
PRR Gangula et al.
BIOLOGY OF REPRODUCTION (2002)
Share Paper
